Idiopathic Pulmonary Fibrosis Clinical Trials in Pittsburgh, Pennsylvania

4 studies are recruiting for idiopathic pulmonary fibrosis in Pittsburgh, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)

    The purpose of the study is to identify genetic and biologic markers that may predict the loss of lung function due to idiopathic pulmonary fibrosis. The studies will compare genetic and biologic markers of samples to changes in symptoms. The ultimate goal is to predict if or when patients are like…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Michelle F MacPherson, Pittsburgh, Pennsylvania
    Run by
    University of Pittsburgh

    See if you can join NCT00373841 on ClinicalTrials.gov

  2. A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medicine called nerandomilast or BI 1015550. The goal of this study is to find out how well people with …

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Allegheny General Hospital, Pittsburgh, Pennsylvania
    Locations
    373 in total
    Run by
    Boehringer Ingelheim

    See if you can join NCT06238622 on ClinicalTrials.gov

  3. WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF)

    Stage
    Phase 2
    Ages
    40 and older
    Site
    WISPer Site in Pittsburg, PA, Pittsburgh, Pennsylvania
    Locations
    71 in total
    Run by
    Mediar Therapeutics

    See if you can join NCT06967805 on ClinicalTrials.gov

  4. Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

    The purpose of this study is to determine whether a lung transplantation prior to bone marrow transplantation (BMT) would allow for restoration of pulmonary function prior to BMT, allowing to proceed to BMT, to restore hematologic function.

    Stage
    Phase 1
    Ages
    18 to 60
    Site
    UPMC Presbyterian, Pittsburgh, Pennsylvania
    Locations
    2 in total
    Run by
    Paul Szabolcs

    See if you can join NCT03500731 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.